RELATED APPLICATIONSThis application is a continuation of U.S. application Ser. No. 17/002,313 filed Aug. 25, 2020, which in turn is a continuation of U.S. application Ser. No. 15/470,191 filed Mar. 27, 2017, now issued U.S. Pat. No. 10,780,215 issued Sep. 22, 2020, which in turn is a continuation of U.S. application Ser. No. 13/832,841 filed Mar. 15, 2013, now U.S. Pat. No. 9,603,995 issued Mar. 28, 2017, each of which is hereby fully incorporated herein by reference.
BACKGROUNDThere are many applications in academic, industrial, and medical fields, as well as others, that benefit from devices and methods that are capable of accurately and controllably delivering fluids, including liquids and gases that have a beneficial effect when administered in known and controlled quantities. Such devices and methods are particularly useful in the medical field where treatments for many patients includes the administration of a known amount of a substance at predetermined intervals. As the number of commercially available delivery systems increase, different types of medication holding cartridges or infusion cartridges are made available.
Insulin-injecting pumps have been developed for the administration of insulin for those suffering from both type I and II diabetes. Continuous subcutaneous insulin injection and/or infusion therapy with portable infusion devices has been adapted for the treatment of diabetes. Such therapy may include the regular and/or continuous injection or infusion of insulin into the skin of a person suffering from diabetes and offer an alternative to multiple daily injections of insulin by an insulin syringe or an insulin pen. Such pumps can be ambulatory/portable infusion pumps that are worn by the user that may use replaceable cartridges. Examples of such pumps and various features that can be associated with such pumps include those disclosed in U.S. patent application Ser. No. 13/557,163, U.S. patent application Ser. No. 12/714,299, U.S. patent application Ser. No. 12/538,018, U.S. Provisional Patent Application No. 61/655,883, U.S. Provisional Patent Application No. 61/656,967 and U.S. Pat. No. 8,287,495, each of which is incorporated herein by reference.
To discriminate between the large varieties of available cartridges, numerous coding schemes have been developed for recognizing the different types of cartridges in order that the delivery of a specific amount of a medicament is allowed by a delivery device. Generally, available systems are limited by the variety of coding schemes they can handle. Existing systems may also be limited by the scope of adjustments made, as a result of obtaining cartridge identification information
Therefore, devices and methods capable of automatically and reliably recognizing a wide variety of cartridges, and implementing useful adjustments to the delivery systems are needed.
SUMMARYSome embodiments include a method for detecting a capacity of a drug delivery reservoir of an infusion cartridge and setting therapeutic parameters of an infusion device setting based on the detected capacity. The method may include obtaining data on the capacity of the drug delivery reservoir, analyzing the obtained data on the capacity of the drug delivery reservoir, determining the setting of therapeutic parameters, and setting one or more therapeutic parameters of an infusion device based on the capacity data.
Some embodiments include a method for detecting a capacity of a collapsible fluid reservoir in an infusion cartridge and setting therapeutic parameters of an infusion device such as a portable or ambulatory infusion pump. The method can include obtaining data on the capacity of the collapsible fluid reservoir, analyzing obtained data on the capacity of the collapsible fluid reservoir to determine the setting of therapeutic parameters of the infusion device, and setting one or more therapeutic parameters of the infusion device. The therapeutic parameters can include a basal rate range, a bolus volume range, a max bolus volume range, and insulin sensitivity. Data on the capacity of the collapsible fluid reservoir can be obtained by reading optical indicia, reading signals from a radio frequency identification (RFID) tag or sensing positions of a plurality switches coupled to mechanical sensors of the infusion device that are registered with surface grooves on the infusion cartridge indicating.
Some embodiments include a method for detecting a volume of a fluid disposed in a collapsible fluid reservoir of an infusion cartridge and setting therapeutic parameters of an infusion device. The method includes obtaining data on the volume of the fluid disposed in a collapsible fluid reservoir; analyzing obtained data on the volume of the fluid to determine the setting of therapeutic parameters; and setting one or more therapeutic parameters of an infusion device. The therapeutic parameters can include a basal rate range, a bolus volume range, a max bolus volume range, and insulin sensitivity. Data on the volume of the fluid disposed in the collapsible fluid reservoir can be obtained by taking a plurality of pressure sensor readings, which are indicative of the volume of the fluid disposed in the collapsible fluid reservoir.
Some embodiments include an infusion device such as a portable infusion pump configured for detecting the capacity of a drug delivery reservoir or a volume of fluid disposed inside an infusion cartridge that may be attached to it, and for setting therapeutic parameters for the infusion device. The infusion cartridge may include a delivery mechanism for effectuating the delivery of fluid. The delivery mechanism may include an axial bore. A first and a second inlet port may be in fluid communication with an interior volume of the axial bore. The second inlet port may be axially spaced from the first inlet port. At least one outlet port, which may be axially spaced from the inlet ports, may also be in fluid communication with the interior volume of the axial bore. A spool may be disposed within the axial bore. The spool may be axially translatable within the axial bore and may form a constrained variable volume in conjunction with an interior surface of the axial bore. The infusion cartridge may also include a drug delivery reservoir for storing fluid. The drug delivery reservoir may include an interior volume that may be in fluid communication with the first inlet port. The infusion device may further include an infusion pump. The infusion pump may include a drive mechanism which may be operatively coupled to the spool. The infusion pump may be configured to impart controlled axial movement to the spool and may translate the constrained variable volume from the inlet ports to the outlet port. The infusion device may also include a processor. The processor may determine the capacity of the drug delivery reservoir or the volume of fluid disposed in the drug delivery reservoir and may set therapeutic parameters. The processor may be coupled to a memory and it may be configured for receiving input data from the memory. The processor may use the input data for generating therapeutic parameters for the infusion device. The memory may be configured for receiving, storing and communicating input data to the processor. A display may be coupled to the processer. The display may be configured for displaying a request to a user for input data. The display may be further configured for receiving user input data in response to the request and for display, communicating that data to the memory.
Certain embodiments are described further in the following description, examples, claims, and drawings. These features of embodiments will become more apparent from the following detailed description when taken in conjunction with the accompanying exemplary drawings.
BRIEF DESCRIPTION OF THE DRAWINGSFIG.1 depicts an embodiment of an interchangeable pump assembly.
FIG.2 depicts an embodiment of an infusion pump having an infusion cartridge embodiment coupled thereto.
FIG.3 depicts a block diagram representing an example of some elements of the infusion pump ofFIG.2.
FIG.4 depicts a perspective view of the infusion pump embodiment ofFIG.2 which can includes a graphic user interface with touch screen capability.
FIG.5 is an exploded view of the infusion cartridge and infusion pump embodiment ofFIG.2 with the infusion cartridge removed from the infusion pump.
FIG.6 is a schematic view partially cut away depicting some internal components of the infusion pump embodiment ofFIG.2 and the disposable infusion cartridge embodiment.
FIG.7 is an elevation view in partial section of a delivery mechanism embodiment of the infusion cartridge ofFIG.6 coupled to a drive mechanism embodiment.
FIG.8A is an elevation view of the infusion cartridge ofFIG.2 depicting locations for indicia.
FIG.8B is a partial exploded view of the infusion pump embodiment ofFIG.5 with the infusion cartridge removed depicting locations of various sensors.
FIG.9 is a flowchart of a method for detecting a capacity of a drug delivery reservoir of the infusion cartridge ofFIG.2 and for setting therapeutic parameters in the infusion pump according to an embodiment of the present disclosure.
FIG.10 is a flowchart of a method embodiment for obtaining data regarding the capacity of the drug delivery reservoir ofFIG.2.
FIG.11 is a flowchart of a method embodiment for obtaining data on a volume of a medicine disposed in the drug delivery reservoir ofFIG.6 by using a pressure metering technique embodiment.
FIG.12 is a flowchart of a method for obtaining data on a volume of a medicine disposed in the drug delivery reservoir ofFIG.6 by using a pressure metering technique embodiment.
DETAILED DESCRIPTIONDisclosed herein are methods and devices for detecting the capacity of a drug delivery reservoir, or a volume of medicine disposed in the drug delivery reservoir, and for setting therapeutic parameters of an infusion device such as a portable or ambulatory infusion pump. Some infusion device, system, and method embodiments discussed herein may account for a wide range of variables in determining an amount of medicament, e.g., insulin, to be infused into a patient over a given period of time. Further, some embodiments discussed herein may allow for refined regulation of the amount of medicament delivered as well as the time during which the medicament is delivered. Some embodiments may include advances in the internal components and the control circuitry, as well as improvements in a user interface. The advances may allow for an accurate regulation of blood glucose levels. Although embodiments described herein may be discussed in the context of the controlled delivery of insulin, delivery of other medicaments, including, for example, glucagon, pramlintide, etc., as well as other applications are also contemplated. Device and method embodiments discussed herein may be used for pain medication, chemotherapy, iron chelation, immunoglobulin treatment, dextrose or saline IV delivery, or any other suitable indication or application. Non-medical applications are also contemplated.
With regard to one particular indication, maintaining appropriate blood glucose homeostasis is an important factor for promoting the length and quality of life of a diabetic patient. Different types of pumps provide a user of a pump with various advantages, though some of them may be mutually exclusive. For example, a portable pump device having a large output display can be easier to read and use when compared to a pump device with a smaller output display. However, those pumps may also have a housing that is generally larger and may require a greater power usage. Large and bulky ambulatory pump devices can be uncomfortable or unwieldy, contributing to problems with user compliance. For example, a user may be less likely to wear a larger pump device while sleeping, or when involved in certain activities. Smaller and more discreet pump systems can be more easily worn at night; however, they may not provide features that some patients may prefer for safety and convenience.
Some embodiments discussed herein may include an interchangeable pump assembly that may provide a user with the flexibility and convenience to alternate between pump devices having various features and advantages at any given moment during a single treatment protocol. In some cases, a single insulin cartridge may be switched between pump devices such as a smaller more discreet pumping device having fewer features and a larger pumping device having more features during a treatment with a single cartridge without compromising the sterility and thus wasting the cartridge.
It should be noted that labels associated with operations described below do not represent an order in a sequence; rather they are used only to uniquely identify each operation. The words, “loaded”, “written”, and “programmed” are used interchangeably when they refer to a processor or a memory device. The terms “pump” and “infusion pump” may be used interchangeably. The phrases “collapsible fluid reservoir” and “drug delivery reservoir” may be used interchangeably. The phrases “infusion cartridge” and “fluid reservoir cartridge” may be used interchangeably in this document. Also the phrases “sensor reading” and “sensor data” may be used interchangeably. Furthermore, as used herein, the term “fluid” shall mean a gas or a liquid, also the terms “fill” and “filling” shall mean increasing the amount of a fluid84 in a collapsible fluid reservoir by some percentage of the total volume of the container up to 100%.
FIG.1 depicts an embodiment of an interchangeable ambulatory infusion pump assembly that may be used in pump embodiments configured to deliver a fluid or fluids from one or more reservoirs, which may be in fluid communication with a delivery mechanism thereof. Theinfusion pump assembly10 may include aninfusion pump12, asecond infusion pump14, aninfusion cartridge16 having an infusion setconnector18, and optionally aglucose meter20. Theinfusion cartridge16 or theglucose meter20 may be functionally and interchangeably inserted in afirst receiving slot22 located in theinfusion pump12 and asecond receiving slot24 located in thesecond infusion pump14. Theinfusion pump12 may have ahousing26 that may be generally larger than asecond housing28 of thesecond infusion pump14. Similarly, theinfusion pump12 may generally include more operating features than thesecond infusion pump14. Some or all of the suitable features, dimensions, materials, and methods of use of theinfusion pump assembly10 may be used or incorporated into any other infusion system, or components thereof, discussed herein. The interchangeability of infusion cartridge embodiments herein may be discussed in the context of transferring an infusion cartridge from theinfusion pump12 to thesecond infusion pump14, having features different from those of theinfusion pump12. However, all of the interchangeability features and methods associated with this type of transfer may also be applied to the transfer of an infusion cartridge from theinfusion pump12 to asecond infusion pump14 having the same features as theinfusion pump12.
FIG.2 illustrates an embodiment of an ambulatoryinfusion pump system100 which includes theinfusion pump12 and theinfusion cartridge16. Thehousing26 of theinfusion pump12 can be of any suitable shape and size. For instance, thehousing26 may be extended and tubular, or in the shape of a square, rectangle, circle, cylinder, or the like. Thehousing26 may be dimensioned so as to be comfortably associated with a user, and/or hidden from view, for instance, within the clothes of a user. In some embodiments, thehousing26 of theinfusion pump12 may have a width of about 2 inches to about 5 inches, a height of about 1 inch to about 3 inches and a thickness of about 0.25 inch to about 0.75 inch; more specifically, thehousing26 may have a width of about 2.5 inches to about 3.5 inches, a height of about 1.5 inches to about 2.5 inches and a thickness of about 0.4 inches to about 0.8 inches. The materials of thehousing26 may vary as well. In some embodiments, the housing of theinfusion pump12 may be a watertight, metal housing that may be taken apart for repairs.
Theinfusion pump12 can include a user interface such as a graphic user interface (GUI)60. TheGUI60 may include an output/display44. The output/display44 may vary as it may be useful for a particular application. The type of visual output/display may include LCD displays, LED displays, plasma displays and OLED displays. The output/display may also be an interactive or touch sensitive screen having an input device, such as a touch screen including a capacitive screen or a resistive screen. In some embodiments, the output/display44 of thefull infusion pump12 may be an OLED screen and the input may be a capacitive touch screen. Theinfusion pump12 may additionally include a keyboard or anotherinput device40 known in the art for data entry, which may be separate from the display. The output/display44 of theinfusion pump12 may also include a capability to operatively couple to a secondary display device such as a laptop computer or a mobile communication device, such as a smartphone or personal digital assistant (PDA).
Theinfusion pump12 may have wired or wireless communication capability for the sending and receiving of data as is known in the art. The wireless capability may be used for a variety of purposes, including updating of any software or firmware for the processor of the device. The wireless communication capability may vary including, e.g., a transmitter and/or receiver, radiofrequency (RF) transceiver, WIFI connection, infrared or Bluetooth® communication device. The wired communication capability may also vary including, e.g., USB or SD port or flash drive port. In some embodiments, theinfusion pump12 may have a transmitter/receiver32, such as a radiofrequency (RF) transceiver, as shown inFIG.3 that may allow the infusion pumps to communicate with one another and may be used interchangeably without loss of data or information during an infusion protocol with aninfusion cartridge16. Theinfusion pump12 may also act as a PDA or a controller to wirelessly control thesecond infusion pump14. For such an embodiment, data may be transferred between the controller of theinfusion pump12 and thesecond infusion pump14 by radio signal, optical transmission or any other suitable means. Thefirst infusion pump12 and thesecond infusion pump14 may be used as stand-alone devices as well.
Theinfusion pump12 may include amemory device30. Thememory device30 may be any type of memory capable of storing data and communicating that data to one or more other components of the device, such as the processor. Thememory device30 may be one or more of a Flash memory, SRAM, ROM, DRAM, RAM, EPROM and dynamic storage. For instance, thememory device30 may be coupled to the processor and configured to receive and store input data and/or store one or more template or generated delivery patterns. For example, thememory device30 may be configured to store one or more personalized (e.g., user defined) delivery profiles, such as a profile based on a user's selection and/or grouping of various input factors or input data. The user input data may include one or more of blood glucose levels, a stress level, a physiological condition, complexity of a meal to be ingested, and an activity level. The user input data may include past generated delivery profiles; recommended delivery profiles; one or more traditional delivery profiles, e.g., square wave, dual square wave, basal rate and bolus profiles; and/or the like. In some embodiments, thememory device30 of the full-featuredinfusion pump device12 may be up to about 10 GB, more specifically, up to about 3 GB, even more specifically, about 1 MB to about 200 MB. In some embodiments, thememory device30 of the full-featuredinfusion pump device12 may be up to about 3 GB, more specifically, up to about 500 MB, and even more specifically, about 200 kB to about 200 MB.
Theinfusion pump12 may include a power charging mechanism, such as a USB port, induction charger, or the like. The power charging system may be used to charge a power storage cell such as a rechargeable battery of theinfusion pump12. Some embodiments may use a rechargeable battery such as a NiCad battery, LiPo battery or NiMH battery. In some embodiments, thepower charging mechanism56 of theinfusion pump12 depicted inFIG.2 may be a USB port. As such, all data may be kept in theinfusion pump12 for quick and easy downloading of data to a computer, other infusion pump device, network etc. using the USB port. TheUSB port56 of theinfusion pump12 may also provide theinfusion pump12 with power charging. In some instances, the power charging mechanism of theinfusion pump12 may be an induction-charging device. In some cases, an advantage of having interchangeable infusion pump devices may be that while one infusion pump device is being used for infusion, the other infusion pump device can be charging.
Theinfusion pump12 may also include programming to allow a processor to set therapeutic parameters and control the overall operation of theinfusion pump12. The therapeutic parameters may include a basal rate range, a bolus volume range, a max bolus volume range, and insulin sensitivity. The processor may include one ormore infusion cartridge16 sensing functionalities, which may allow the processor to receive data from various sources. The processor may collate data, parse the same, calculate a volume of a fluid disposed in the drug delivery reservoir or detect the reservoir capacity of theinfusion cartridge16 and may set therapeutic parameters for an infusion cycle. For example, the processor may receive input data from one or more pressure sensors which may be used for setting therapeutic parameters.
FIG.3 illustrates a block diagram of some of the features that may be incorporated within thehousing26 of theinfusion pump12. Theinfusion pump12 can include the memory device the transmitter/receiver32, analarm34, aspeaker36, a clock/timer38, theinput device40, theprocessor42, the user interface that may beGUI60 having a touchsensitive screen46 with input capability, adrive mechanism48, and anestimator device52. Thememory device30 may be coupled to theprocessor42 to receive and store input data and to communicate that data to theprocessor42. The input data may include user input data and non-user/sensor input data. The input data from thememory device30 may be used to generate therapeutic parameters for theinfusion pump device12. TheGUI60 may be configured for displaying a request for the user to input data and for receiving user input data in response to the request, and communicating that data to the memory.
Theinfusion pump12 includes theprocessor42 that functions to control the overall functions of the device. Theprocessor42 may communicate with and/or otherwise control the drive mechanism, output/display, memory, transmitter/receiver, and the like. Theprocessor42 of some embodiments of theinfusion pump12 may communicate with a processor of another device, for example, a radio-frequency identification (RFID) reader through the transmitter/receiver. Theprocessor42 may include programming that can be run to control the infusion of insulin or other medicament from the cartridge, the data to be displayed by the display, the data to be transmitted via the transmitter, etc. Theprocessor42 may also include programming that may allow the processor to receive signals and/or other data from an input device, such as a sensor that may sense pressure, temperature, a continuous glucose monitor and other similar devices. Theprocessor42 may determine the capacity of the drug delivery reservoir and/or the volume of fluid disposed in the drug delivery reservoir and may set therapeutic parameters based on its determination.
As discussed above thehousing26 of theinfusion pump12 may be functionally associated with an interchangeable and aremovable glucose meter20 and/orinfusion cartridge16. Theinfusion cartridge16 may have anoutlet port54 that may be connected to an infusion set (not shown) via an infusion set connector18 (seeFIG.5).
Theprocessor42 may also include additional programming to allow theprocessor42 to learn user preferences and/or user characteristics and/or user history data to, for example, implement changes in use, suggestions based on detected trends, such as, weight gain or loss, and may include programming that allows the device to generate reports, such as reports based upon user history, compliance, trending, and/or other such data. Additionally, infusion pump embodiments of the disclosure may include a “power off” or “suspend” function for suspending one or more functions of the device, such as, suspending a delivery protocol, and/or for powering off the device or the delivery mechanism thereof. For some embodiments, two or more processors may be used for controller functions of the infusion pumps, including a high power processor and a low power processor used to maintain programming and pumping functions in low power mode, in order to save battery life.
Referring toFIG.4, a front view of theinfusion pump12 is shown. Theinfusion pump12 may include a user-friendly GUI60 on afront surface58 of theinfusion pump12. TheGUI60 may include the touchsensitive screen46 that may be configured to display a variety of screens used for displaying data, facilitating data entry by a patient, providing visual tutorials, as well as other interface features that may be useful to the patient operating theinfusion pump12.
FIG.5 depicts theinfusion pump system100 with theinfusion cartridge16 detached from theinfusion pump12. Theinfusion pump12 may include anattachment mechanism64 positioned within afirst receiving slot22 that corresponds to areceiving mechanism62 at an end of theinfusion cartridge16. The attachment and receiving mechanisms may be configured to removably couple an interior volume of the cartridge with a volume of the pump that may be sealed from the surrounding environment with the coupling able to retain a fluid within the volumes even under significant pressure. The attachment may be so configured and suitable for producing a leak free detachable coupling that can withstand significant pressure. Theinfusion cartridge16 may be removably attached to thehousing26 of theinfusion pump12 for fluid delivery. In this embodiment, theattachment mechanism64 may include apneumatic tap66 having an O-ring or other sealing device. Thecorresponding receiving mechanism62 positioned on an end of theinfusion cartridge16 may include a port through which thepneumatic tap66 may be inserted. Areservoir fill port76 may be disposed on a top portion of theinfusion cartridge16. In some cases, the desired fluid may be manually dispensed from the interior volume of a syringe or other device, through thereservoir fill port76 into the interior volume of theinfusion cartridge16.
Referring toFIGS.6-7, acollapsible fluid reservoir68 of theinfusion cartridge16 may be bounded by or disposed within a flexible membrane orlayer72. Thecollapsible fluid reservoir68 may include aninterior volume74 in fluid communication with areservoir inlet port108 of anaxial bore104 of adelivery mechanism120. A top portion of thecollapsible fluid reservoir68 may be clamped or otherwise sealed to an extension or aboss82 of thereservoir inlet port108 that may extend into a firstinterior volume80. In this configuration, theinterior volume74 of thecollapsible fluid reservoir68 may be isolated or sealed from the surrounding environment except for thereservoir inlet port108, which may be in fluid communication with theaxial bore104 of thedelivery mechanism120.
A substantially rigid shell86 may be disposed about thecollapsible fluid reservoir68 with a firstinterior volume80 that may contain thecollapsible fluid reservoir68. The firstinterior volume80 of theinfusion cartridge16 may be disposed between theouter surface88 of theflexible membrane72 and an interior surface90 of the rigid shell86. Avent inlet port112 may be in fluid communication with the firstinterior volume80 and theaxial bore104 of thedelivery mechanism120. TheGUI60 ofFIG.2 may be operatively coupled to acontroller50, which may include at least oneprocessor42, amemory device30, and connective circuitry or other data conduits that couple the data generating and data managing components of the device. A power storage cell in the form of abattery98 may be rechargeable and may also be disposed within thehousing26. Data generating or managing components of the device may include the processor(s)42, thememory device30, theGUI60, a plurality of sensors including pressure sensors, temperature sensors, optical sensors, mechanical sensors and the like. Other components such as a vibratory motor96, thespeaker36, thebattery98, and anelectric motor170 of thedrive mechanism48 may also be operatively coupled to thecontroller50. Connective circuitry may include conductive wiring such as copper wiring, fiber optic conduits, RF conduits and the like.
With reference again to theinfusion cartridge16 generally shown inFIG.6, thevent inlet port112 may be disposed on thedelivery mechanism120 in fluid communication with the firstinterior volume80 disposed between theoutside surface88 of the flexible material ormembrane72 of thecollapsible fluid reservoir68 and the inside surface90 of the substantially rigid shell or case86 of theinfusion cartridge16. Thecontroller50 may be coupled to at least onepressure sensor92 which may be disposed in communication with achamber94 which may be in communication with the firstinterior volume80 by means ofattachment mechanism64 and receivingmechanism62. Thecontroller50 may be configured to generate signals to thedrive mechanism48 to displace thespool106 of thedelivery mechanism120 based on a reading of thepressure sensor92.
FIG.7 depicts a portion of theinfusion cartridge16 including thedelivery mechanism120, as well as a portion of thedrive mechanism48 of theinfusion pump12. Thedelivery mechanism120 may be configured to deliver fluid from thecollapsible fluid reservoir68 via a collapsible or variable volume element of thespool106. For the embodiments discussed herein, the variable volume elements may include constrained variable volume elements that may be mechanically constrained to vary between a minimum volume and a maximum volume. Thedelivery mechanism120 may include adelivery mechanism body102, or housing, and anaxial bore104 disposed in thedelivery mechanism body102. Theaxial bore104, may have a substantially round transverse cross section and includes adistal end144, aproximal end148 disposed towards thedrive mechanism48 of theinfusion pump system100, areservoir inlet port108, afluid outlet port114, avent inlet port112, and avent outlet port116. Thespool106, may also have a substantially round transverse cross section and may be slidingly disposed within theaxial bore104 to form a constrainedvariable volume122 and a second sealedvolume154 with theaxial bore104.
The constrainedvariable volume122 of thedelivery mechanism120 may be positionable to overlap thereservoir inlet port108 independent of an overlap of thefluid outlet port114. The constrainedvariable volume122 may be formed between afirst seal140 around thespool106, asecond seal142 around thespool106, an outer surface of the spool body between the first andsecond seal140 and142 and an interior surface of theaxial bore104 between the first andsecond seal140 and142. The first andsecond seals140 and142 may be axially moveable relative to each other so as to decrease/increase a volume of the constrainedvariable volume122, as when the first andsecond seals140 and142 move away from each other, decreasing the constrainedvariable volume122, or when the first andsecond seals140 and142 may move closer together, increasing thevariable volume122.
Thesecond seal142 may be disposed on aproximal section134 of thespool106 and may move in conjunction with movement of theproximal section134 of thespool106. A proximal end of thespool136 may be coupled to aball portion178 of adrive shaft176 of thedrive mechanism48 of theinfusion pump12. Thedrive mechanism48 includes a rack andpinion mechanism174 actuated by anelectric motor170 through agear box172. As such, thesecond seal142 may move or translate axially in step with axial translation of thespool106 and driveshaft176. Thefirst seal140, however, may be disposed on adistal section128 of thespool106, which may be axially displaceable with respect to the main section190 of thespool106. Thedistal section128 of thespool106 may be coupled to the main section of the spool by anaxial extension156 that may be mechanically captured by acavity158 in themain section132 of thespool106. This configuration may allow a predetermined amount of controlled axial movement between thedistal section128 of the spool and themain section132 of thespool106 and may translate the constrainedvariable volume122 from thereservoir inlet port108 to thefluid outlet port114. This configuration may expand or contract the constrainedvariable volume122 of thespool106 by exerting translational axial force through a boundary section of the constrainedvariable volume122.
For some embodiments, a volume of a “bucket” of fluid dispensed by a complete and full dispense cycle of thespool106 may be approximately equal to the cross-sectional area of theaxial bore104 multiplied by the length of displacement of the captured axial extension of the spool for thedistal section128. The complete bucket of fluid may also be dispensed in smaller sub-volumes increments, as small as a resolution of thedrive mechanism48 allows. For some embodiments, a dispense volume or bucket defined by the constrainedvariable volume122 of thedelivery mechanism120 may be divided into about 10 to about 100 sub-volumes to be delivered or dispensed. In some cases, the maximum axial displacement between thedistal section128 and main section of thespool132 may be about 0.01 inch to about 0.04 inch, and, more specifically, about 0.018 inch to about 0.022 inch.
For some embodiments, theaxial bore104 of the delivery mechanism may have a transverse dimension or diameter of about 0.04 inches to about 0.5 inches, and, more specifically, about 0.08 inches to about 0.15 inches. For some embodiments, thespool106 may have a length of about 10 mm to about 40 mm, and, more specifically, about 15 mm to about 20 mm. Thespool106 and housing of thedelivery mechanism48 may be made from any suitable material or materials including polymers or plastics such as polycarbonate, PEEK, thermoplastics, cyclic olefin copolymer, and the like. In some cases, the seals disposed on the spool may have an outer transverse dimension or diameter that may be slightly larger than that of thespool106. In some instances, the seals on the spool may have an axial thickness of about 0.01 inches to about 0.03 inches and may be made from materials such as butyl, silicone, polyurethanes or the like, having a shore hardness of about 65 A to about 75 A, and more specifically, about 70 A.
In some instances, asecond volume154 of thedelivery mechanism120 may be formed by thespool106 andaxial bore104 of thedelivery mechanism48. Thesecond volume154 may be also be formed by athird seal150 disposed around thespool106 and afourth seal152 also disposed around the spool and axially separated from thethird seal150. In some instances, the axial separation between the third andfourth seals150 and152, forming thesecond volume154, may be greater than the axial separation between thevent inlet port112 and thevent outlet port116 of theaxial bore104. Thesecond volume154 may also be formed by an outside surface of thespool106 between the third andfourth seals150 and152 and an inside surface of theaxial bore104 between the third andfourth seals150 and152.
Thesecond volume154 may be axially displaceable with the movement of thespool106, and may also be positionable by such axial displacement, in order to simultaneously overlap thesecond volume154 with thevent inlet port112 and thevent outlet port116 of theaxial bore104. Such an overlap of both thevent inlet port112 and thevent outlet port116 may put these ports in fluid communication with each other and may allow an equilibration of pressure between the firstinterior volume80 of theinfusion cartridge16 and the environment surrounding thevent outlet port116 to vent theinterior volume80. In most cases, thevent outlet port116 may be in communication with the atmosphere and air may pass from the environment surrounding thevent outlet port116, through thesecond volume154 of theaxial bore104 and into thefirst volume80, to replace the fluid dispensed subsequent to the last vent cycle. When thevent inlet port112 and ventoutlet port116 do not share a common volume formed by the spool andaxial bore104 of thedelivery mechanism120, they are typically isolated and no venting of the volume takes place.
In operation, thespool106 and the volumes formed between thespool106, theaxial bore104 and thecircumferential seals140,142,150 and152 disposed on the spool of thedelivery mechanism120 are typically translated in a proximal and distal direction in order to move the volumes into and out of communication with the various ports of theaxial bore104. This axial movement in alternating proximal and distal directions of thespool106, within theaxial bore104, may be used to put the various ports in fluid communication with translatable volumes of thedelivery mechanism120 and other ports of the mechanism. For reliable operation, it may be desirable, in some circumstances, for thespool106 and thecircumferential seals140,142,150 and152 disposed about thespool106 to move smoothly within theaxial bore104 of thedelivery mechanism120, while maintaining a seal between an outside surface of thespool106 and an inside surface of theaxial bore104. It may also be desirable for thecircumferential seals140,142,150 and152 disposed on thespool106 to move axially back and forth within theaxial bore104, while maintaining a seal and with a minimum of friction. Achieving these features of thespool106 may be facilitated with the use of particular seal configurations, or gland configurations used to house the seals of the spool embodiments.
Referring toFIG.8A, an elevation view of theinfusion cartridge16 is shown depicting locations of indicia for capacity information. For some embodiments, theinfusion cartridge16, and any of the collapsible fluid reservoir cartridges discussed herein, may include one or more optically readable or detectable indicia, for example, a barcode type stripe168 or a quick response code (QRC)label166. In some embodiments the optically detectable indicium may be formed by up to three narrow blank lightreflective stripes164. The threereflective stripes164 may represent three bits of data. Each of the light reflective stripes or the optically readable indicia may be configured to be detected by a corresponding optical reader device of theinfusion pump system100. In some cases such light reflective stripes may reflect a beam of light omnidirectionally or unidirectionally.
FIG.8B is a partial view of theinfusion pump device12 depicting locations of light sources and various readers. The optical reader device may be one of a bar code reader, a QRC reader, an array of photo sensors, or a combination of the above along with any other suitable sensors or detectors. In some instances infusion cartridge detection may rely on continuous readings of the three blank light reflective stripes. For some embodiments, a light source may illuminate one or more of the light reflecting stripes once the infusion cartridge is properly placed in the infusion pump device. A reflected beam of light from the light reflecting stripes may hit the photo sensor generating a digital value of 1 or other suitable indicium. A non-zero digital value may be used to indicate the presence of the infusion cartridge.
For some embodiments, the optical reader device may be in operative communication with thecontroller50 orprocessor42 of the pump. The encoder device may alternatively be an RFID tag or the like that may transmit data to a reader such as a data receiving processor, for example a RFID reader or the like. Such encoder device embodiments may include the ability to securely transmit and store data, via encryption, to prevent unauthorized access or tampering with such data. The identification of theinfusion cartridge16 and its content may be used by the controller to set or to adjust certain dispense parameters or any other suitable parameters.
Referring now toFIG.9, a flowchart illustrates amethod embodiment200 of setting parameters of an infusion pump such asinfusion pump12.Method200 may be used to determine the capacity of the collapsible fluid reservoir and/or the volume of medicine disposed in a collapsible fluid reservoir and to set delivery/therapeutic parameters of an infusion pump.Method200 may start atoperation210, during which aninfusion cartridge16 containing thecollapsible fluid reservoir68 may be loaded into theinfusion pump12. Inoperation230, data regarding the capacity of thecollapsible fluid reservoir68 and/or the volume of medicine disposed in thecollapsible fluid reservoir68 may be obtained by using various measurements and sensing techniques as discussed above. Inoperation250, the obtained data may be analyzed by aprocessor42 to determine therapeutic parameter settings to be loaded into a memory of aninfusion pump12 for access by a processor. Inoperation270, the therapeutic parameter setting is loaded into the memory device for access by the processor.
Some of the method embodiments described herein may detect/determine the capacity of thereservoir68 of theinfusion cartridge16. For some embodiments, thecollapsible fluid reservoir68 may have a volume of about 200 units, 300 units, and 500 units. Based on the detected capacity of theinfusion cartridge16, therapeutic parameter of theinfusion pump12 may be set. For example, the basal rate range, the bolus volume, and/or the max bolus volume range may be set lower for infusion cartridges with a smaller volume than for infusion cartridges with a larger volume. Furthermore, patients with high insulin sensitivity (where insulin sensitivity is defined as, units of insulin per mg/dl of blood glucose change) may be treated using a small capacity insulin cartridge.
FIG.10 is a flowchart of amethod embodiment330 which depicts various measurements and sensing techniques employed for obtaining sensor data (volume data or capacity data) on the volume of fluid stored in thecollapsible fluid reservoir68, or a fluid capacity of theinfusion cartridge16 that may be loaded into theinfusion pump12. Inoperation332, capacity data encoded in an optical code may be obtained by reading the optical code represented by reflected light using one or moreoptical sensors126 as discussed above to obtain capacity data or detect theinfusion cartridge16. In some cases in addition to obtaining capacity data, a continuous monitoring of the presence of the lightreflective stripes164 may allow theprocessor42 to determine whether theinfusion cartridge16 is present in the receiving slots or it has been removed or is inadvertently disconnected.
A method for detecting presence of an infusion cartridge in an infusion device can include illuminating the lightreflective stripes164 on theinfusion cartridge68, detecting reflected light from the reflectingstripes68, determining whether data represented by the reflected light has a predetermined value and generating an audible warning signal indicating absence of a cartridge when data represented by the reflected light differs from the predetermined value.
Inoperation333, capacity data may be obtained by using a bar code reader to read a bar code strip or a QRC label on the infusion cartridge. Inoperation334, capacity data may be obtained by decoding the positions of switches. The switches may be operated by mechanical sensors that may be registered with surface grooves or dimples on the cartridge. In some instances, a groove configuration may be used to indicate the fluid capacity of theinfusion cartridge16. Inoperation335, capacity data may be obtained via a RFID reader. The RFID reader may read an RFID tag that may be affixed to the cartridge. The RFID tag may store data indicating the capacity of the collapsible fluid reservoir. The RFID reader may be an external or an internal device to the infusion pump device. In cases where the RFID reader is an external device, the RFID reader data may be wirelessly communicated with the infusion pump device.
Inoperation340, data may be obtained by reading a pressure sensor disposed in the cartridge during consecutive pressure measuring cycles. Changes in the pressure sensor readings may be indicative of the volume of fluid disposed in the collapsible fluid reservoir. Data on the capacity of the collapsible fluid reservoir may also be obtained by using a backstroke volume (Vbackstroke), which is indicative of the capacity of thecollapsible fluid reservoir68 if the measurements are taken when the system is known to be empty of fluid. An example of a Vbackstrokedetermination technology is disclosed in U.S. patent application Ser. No. 12/714,299 which is incorporated herein by reference in its entirety.
An additional method of determining the identity or size classification of an infusion pump fluid cartridge may include reading a resistance value of a resistor (not shown) that is embedded in theinfusion cartridge16 as is coupled to theprocessor42 of theinfusion pump12. Theprocessor42 may measure a resistance value of the embedded resistor to determine the size of theinfusion cartridge16. For example, different resistor values may indicateinfusion cartridges16 with different sizes ofcollapsible fluid reservoirs68. For example, a 10 Ohm embedded resistor may indicate aninfusion cartridge16 with a small sizecollapsible fluid reservoir68 and a 20 Ohm embedded resistor may indicate aninfusion cartridge16 with a large sizecollapsible fluid reservoir68.
FIG.11 is a flowchart depicting amethod embodiment440 for using pressure sensor readings to obtain the volume of fluid disposed in thecollapsible fluid reservoir68. Function-block450 shows the operations of theinfusion pump12 for executing a pressure metering cycle.Method embodiment440 may start atoperation451. Inoperation452, a spool of aninfusion cartridge16 may be positioned in a fill position. Inoperation454, a first pressure measurement may be performed in theinterior volume80. Inoperation456, the constrainedvariable volume122 may be filled with a known amount of fluid removed from thecollapsible fluid reservoir68. Inoperation458, a second pressure measurement may be performed in theinterior volume80. Inoperation460, readings of the first and second pressure measurements may be recorded. Inoperation470, the volume of fluid disposed in thecollapsible fluid reservoir68 may be calculated based on the first and second sensor readings. Inoperation480, the spool of theinfusion cartridge16 may be positioned in a dispense position. Inoperation490, fluid from the constrainedvariable volume122 may be dispensed.
FIG.12 is a flowchart depicting amethod embodiment540 for using pressure sensor readings to obtain the volume of fluid disposed in the collapsible fluid reservoir.Method embodiment540 may start atoperation542 during which an empty infusion cartridge may be loaded into theinfusion pump12. Inoperation550, a first pressure metering cycle may be executed. Inoperation560, following the pressure metering cycle, a first pressure sensor reading may be recorded. Inoperation558, if it is determined that there is another infusion cartridge available, the method may loop back tooperation544 or548 respectively; otherwise, the method may exit inoperation570. Inoperation544, an infusion cartridge with a known volume of fluid may be loaded into theinfusion pump12Operation544 may be followed with a second execution of thepressure metering cycle550 and therecording560 of a second pressure sensor reading. Inoperation546, a target infusion cartridge, i.e. an infusion cartridge that is intended to be used for a present therapy, may be loaded into the infusion device. Operation548 may be followed with a third execution of thepressure metering cycle550, and therecording560 of a third pressure sensor reading. Inoperation570, the volume of fluid disposed in the target infusion cartridge may be calculated based on the first, second and third pressure sensor readings.
Some of the above described method embodiments may detect/determine the capacity of thecollapsible fluid reservoir68 of theinfusion cartridge16. For some embodiments, thecollapsible fluid reservoir68 may have a volume of about 200 units, 300 units, and 500 units. Based on the detected capacity of theinfusion cartridge16, therapeutic parameter of theinfusion pump12 may be set. For example, the basal rate range, the bolus volume, and/or the max bolus volume range may be set lower for infusion cartridges with a smaller volume than for infusion cartridges with a larger volume. Furthermore, patients with high insulin sensitivity (where insulin sensitivity is defined as, units of insulin per mg/dl of blood glucose change) may be treated using a small capacity insulin cartridge.
Some of the above-described methods may determine the volume of medicine disposed in the drug delivery reservoir. Based on this volume, therapeutic parameters of the infusion pump may be precisely set or adjusted.
With regard to the above detailed description, like reference numerals used therein may refer to like elements that may have the same or similar dimensions, materials, and configurations. While particular forms of embodiments have been illustrated and described, it will be apparent that various modifications can be made without departing from the spirit and scope of the embodiments herein. Accordingly, it is not intended that the invention be limited by the forgoing detailed description.
The entirety of each patent, patent application, publication, and document referenced herein is hereby incorporated by reference. Citation of the above patents, patent applications, publications and documents is not an admission that any of the foregoing is pertinent prior art, nor does it constitute any admission as to the contents or data of these documents.
Modifications may be made to the foregoing embodiments without departing from the basic aspects of the technology. Although the technology may have been described in substantial detail with reference to one or more specific embodiments, changes may be made to the embodiments specifically disclosed in this application; yet, these modifications and improvements are within the scope and spirit of the technology. The technology illustratively described suitably herein, may be practiced in the absence of any element(s) not specifically disclosed herein. The terms and expressions which have been employed are used as terms of description and not of limitation and use of such terms and expressions do not exclude any equivalents of the features shown and described, or portions thereof, and various modifications are possible within the scope of the technology claimed. Although the present technology has been specifically disclosed by representative embodiments and optional features, modification and variation of the concepts herein disclosed may be made, and such modifications and variations may be considered within the scope of this technology.